Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Favorable demographics, e-commerce to drive China OTC healthcare market to $29.3 billion in 2026, forecasts GlobalData

China has rapidly emerged as one of the world’s largest over-the-counter (OTC) healthcare markets, driven by growing aging population, rapid urbanization, and the e-commerce boom. Against this backdrop, the Chinese OTC healthcare market is projected to grow at a compound annual growth rate (CAGR) of 3.3% from CNY158.6 billion ($24.6 billion) in 2021 to CNY187 […]
Read more

GlobalData sees 200% QoQ jump in Twitter influencer discussions around ‘layoff’ during Q2 2022

Companies across industries are announcing mass layoffs in response to the ongoing volatile macroeconomic environment in the wake of the COVID-19 pandemic. In this regard, Twitter influencer conversations around ‘Layoff’ have witnessed a staggering 200% quarter-on-quarter (QoQ) growth in Q2 (April-June*) 2022, over the previous quarter, according to the Social Media Analytics Platform of GlobalData, […]
Read more

Qualcomm leads global cyber hygiene efforts, reveals GlobalData

The growing adoption of digital technologies in pursuit of new business models and enhanced customer experiences has led to an increase in the number of cyber threats to users and companies. As a result, cyber risks such as social media security attacks, business interruption from system failures, data breaches, financial frauds, and cyber extortion are […]
Read more

GlobalData forecasts Australia over-the-counter healthcare market to surpass $5 billion in 2026

A rapidly aging population with a high risk of geriatric illnesses coupled with rising health costs due to COVID-19 make Australia a promising market for over-the-counter (OTC) healthcare. The launch of innovative non-prescription drugs and therapeutics, and smartphone apps for telemedicine is further driving the market growth. Consequently, the Australian OTC healthcare market is set […]
Read more

Domestic demand, trade partnerships to drive ASEAN growth above 5% in 2022, forecasts GlobalData

Recovering domestic demand and trade partnerships will play a pivotal role in driving the growth of the Association of Southeast Asian Nations (ASEAN) at 5.2% in 2022 following a weak performance of 2.9% in 2021, forecasts GlobalData, a leading data and analytics company. Animesh Pareek, Economic Research Analyst at GlobalData, comments: “Regardless of the limited […]
Read more

China to account for 24% of upcoming crude oil refinery projects in Asia through 2026, reveals GlobalData

China is expected to commence operations of 44 crude oil refinery projects during 2022-2026, accounting for 24% of all crude oil refinery projects in Asia, driven by growing refining capacity to meet the rising demand for plastics and petroleum products, finds GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Crude Oil Refinery New-Build […]
Read more

Asia to continue to dominate global LNG regasification capacity additions through 2026, forecasts GlobalData

Asia is set to continue to dominate the global liquefied natural gas (LNG) regasification capacity additions, contributing around 75% of the total LNG liquefaction capacity additions between 2022 and 2026, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest regasification industry report, ‘LNG Regasification Terminals Capacity and Capital Expenditure (CapEx) Forecast by Region, Countries […]
Read more

Twitter influencer conversations around buy now, pay later record 40% QoQ growth in Q2 2022, finds GlobalData

Buy now, pay later (BNPL) has emerged as one of the most popular online payment methods, as surge in digital payments during the COVID-19 pandemic kindled the growth of BNPL consumer lending. Against this backdrop, influencer conversations on Twitter around BNPL recorded a 40% growth in Q2 2022 (April-June*) over the previous three months, according […]
Read more

Multiple myeloma patients in China close to getting first homegrown CAR-T cell therapy, says GlobalData

Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma is not yet available in China. However, the China National Medical Products Administration (NMPA) has recently accepted the new drug application (NDA) for Innovent and IASO Biotherapeutics’ CAR-T therapy equecabtagene autoleucel to treat relapsed and/or refractory multiple myeloma (R/R MM). Following the approval, it will be […]
Read more

AgriTech accelerates agricultural transformation for progressive and sustainable future, says GlobalData

The demand for more food to feed the world is escalating because of population growth and climate unpredictability. As a result, top agriculture companies are using AgriTech to optimize farming and transform the agricultural economy for a progressive and sustainable future, reveals GlobalData, a leading data and analytics company. Top AgriTech companies are using notable […]
Read more
1 … 134 135 136 137 138 … 209